JHVEPhoto/iStock Editorial via Getty Images Shares of Dexcom ( NASDAQ: DXCM ) fell 16% in post-market trading Thursday after the company released its Q3 earnings report which showed only modest topline growth over last year’s quarter. Dexcom reported that revenue rose 2%, year-over-year, on a reported basis to $994M, with U.S.
revenue slipping.